APP and Alzheimer disease: These Abeta-Th1 and Abeta-Th17 clones were transferred into APPswe/PSEN1dE9 mice, which exhibit characteristics of AD, resulting in accelerated memory impairment, systemic inflammation, increased amyloid burden, heightened microglial activation, and exacerbated neuroinflammation [132].